NSE - Delayed Quote INR

Suven Pharmaceuticals Limited (SUVENPHAR.NS)

Compare
1,256.30 -20.50 (-1.61%)
At close: 3:30 PM GMT+5:30
All numbers in thousands
Breakdown
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Total Assets
22,540,865.00
19,657,438.00
18,295,873.00
14,744,651.00
--
Total Liabilities Net Minority Interest
2,034,230.00
2,305,595.00
3,024,069.00
2,936,668.00
--
Total Equity Gross Minority Interest
20,506,635.00
17,351,843.00
15,271,804.00
11,807,983.00
--
Total Capitalization
20,506,634.00
17,397,485.00
15,556,207.00
12,163,992.00
--
Common Stock Equity
20,506,634.00
17,351,843.00
15,271,803.00
11,808,083.00
--
Capital Lease Obligations
264,211.00
11,788.00
15,538.00
18,072.00
--
Net Tangible Assets
19,887,377.00
16,729,940.00
15,249,439.00
11,782,179.00
--
Working Capital
11,562,906.00
8,522,799.00
9,176,380.00
3,450,372.00
--
Invested Capital
20,892,387.00
18,043,463.00
16,227,537.00
13,220,368.00
--
Tangible Book Value
19,887,377.00
16,729,940.00
15,249,439.00
11,782,179.00
--
Total Debt
649,964.00
703,408.00
971,272.00
1,430,357.00
--
Net Debt
--
43,592.00
510,096.00
1,340,462.00
1,735,952.00
Share Issued
254,564.96
254,564.96
254,564.96
254,564.96
--
Ordinary Shares Number
254,564.96
254,564.96
254,564.96
254,564.96
--
3/31/2020 - 3/9/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers